NCT06010121 is a NA clinical trial of Liposomal Vitamin D in Bioavailability of Vitamin D, sponsored by AronPharma Sp. z o. o..

Who is sponsoring NCT06010121?

NCT06010121 is sponsored by AronPharma Sp. z o. o..

What drugs are being tested in NCT06010121?

Interventions in NCT06010121: Liposomal Vitamin D, Traditional Vitamin D.

What condition does NCT06010121 study?

NCT06010121 studies Bioavailability of Vitamin D.

Is NCT06010121 still recruiting?

NCT06010121 is currently completed. Last updated 25 August 2023.

Last reviewed 2023-08-25 · How we verify

NCT06010121

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Bioavailability of Liposomal and Traditional Formulation of Vitamin D3

Completed NA Last updated 25 August 2023

What this trial tests

NA trial testing Liposomal Vitamin D in Bioavailability of Vitamin D in 27 participants. Completed in 6 June 2023.

Timeline

17 February 2023

Primary endpoint
6 June 2023

6 June 2023

Quick facts

Lead sponsor	AronPharma Sp. z o. o.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	other
Enrollment	27
Start date	17 February 2023
Primary completion	6 June 2023
Estimated completion	6 June 2023
Sites	1 location across Poland

Drugs / interventions tested

Liposomal Vitamin D
Traditional Vitamin D

Conditions studied

Bioavailability of Vitamin D — all drugs for Bioavailability of Vitamin D →

Sponsor

AronPharma Sp. z o. o.

Who can join

Adults 18 to 60, any sex, with Bioavailability of Vitamin D. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study was to compare the profiles of 25-hydroxyvitamin D serum concentration in healthy adults after 4 weeks of using vitamin D supplementation either in a liposomal or a traditional formulation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other AronPharma Sp. z o. o. trials

Trials by the same sponsor.

NCT06017661 — Investigation of a Polyphenol-rich Preparation as Support for Oncology Patients Undergoing Gastrointestinal Tumor Resect · NA · unknown
NCT05994638 — Polyphenol Rich Aerosol as a Support for Cancer Patients in Minimizing Side Effects After a Radiation Therapy · NA · unknown
NCT06004570 — Effects of a Combination of Polyphenol-rich Extracts on the Protection of Retinal Cells Against Blue Light in the Preven · NA · completed
NCT05994586 — The Efficacy of AP029 Mix in Patients With Impaired Carbohydrate Metabolism · NA · unknown
NCT05990764 — Effects of a Combination of Polyphenol-rich Extracts, Prebiotics, and Hydrolyzed Fiber on the Quality of Life of Patient · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06010121 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by AronPharma Sp. z o. o.
Last refreshed: 25 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06010121.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing